Information on IMD74
Name: Immunodeficiency 74, COVID-19 related | Acronym: IMD74
Alt. names:
Gene: TLR7 | MOI: X-linked recessive | Mechanism of action:
No. of cases in DB: 0 | First reported in: 2020
Last updated on: 2023-02-28 by
Description
Individuals may demonstrate susceptibility to severe COVID-19, and awareness may allow preventative measures (such as adhering to practices to reduce the chance of infection). Refs. PMIDs: 32706371
Management
Description of management option has not been reviewed yet.
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of clinical findings
[Considering only Definitive and Possible cases]
| Rank | Clinical phenotype | Present | Absent | Unreported |
|---|---|---|---|---|
| 1 | Severe SARS-CoV-2 infection |
4 (99.9%) | 0 (0.0%) | 0 (0.0%) |
| 2 | Severe viral infection |
4 (99.9%) | 0 (0.0%) | 0 (0.0%) |
Age of onset
distribution
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
Summary of treatment outcomes
[Considering only Definitive and Possible cases]
| Treatment ⓘ | Responses & clinical indications |
|---|
Please mind that full curation of this condition has not started yet. Please contact us if you want to volunteer.
0 reported cases added to GenIA
| SubjectID | Sex | Fam.ID | AD | AFM | Validity | Country | Population | Reference & Pub.code |
|---|
AD: Age at genetic diagnosis; AFM: age at first manifestation; PMID: PubMed ID; GRID: GenIA reference ID (ref. not in PubMed).